Charles H. Pierce, MSc, MD, PhD, FCP, CPI

Consultant in Pharmaceutical and Medical Research


Working to benefit:

Pharmaceutical and medical research organizations, biotechnology companies, continuing education organizations, and medical academia.

Present Activities Include:

Metabolic and Atherosclerotic Research Center (Unit of Medpace, Inc)
Medical Director / Investigator

  • The MARC is the result of the life work of Dr. Evan Stein, who has developed the unit to conduct Phase II and Phase III studies on the control of Hypercholesterolemia and hyperlipidemia. A good descriptor is 'Saving Lives One Study at a Time'

Past Activities Include:

Harrison Clinical Research, GmbH
Medical and Regulatory Affairs Consultant

  • HCR, a full-service Medical Research Organization (CRO), is headquartered in Munich, Germany. HRC has received recognition of its high international standards by attaining ISO 9001 for the last 10 years for quality management in all aspects of Clinical research. For more information:
    See also

CTI Clinical Trials and Consulting Services
Medical Director - Consulting

Medical Practice
Ohio License: 8-2173-P

Clinical Investigator Information:

Can't read Portable Document Format (PDF) Files?
Take a moment to Get The Free Acrobat Reader: Adobe Acrobat Reader allows you to view, download, navigate, and print PDF files.


Home | Biography | CurriculumVitae | Investigators  | Resources | Viewpoints | Contact

Copyright 2000-2001. Pierce1 Consulting. C.H. Pierce, MD, PhD, FCP, CPI - All Rights Reserved. HONcode
We ascribe to the HONcode principles
of the Health On the Net Foundation.

Mission: To provide educational information regarding medical topics to interested persons.
The Information provided on is designed to support, not replace, the relationship that exists between site visitors and her/his physician.
Any information collected by this site will never be passed on to any third party unless required by law.
This web site is self funded and does not host any form of advertising.
Last Updated May 2012.